Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history
Brad T. Tinkle(Ghent University Hospital), Howard P. Levy(Johns Hopkins University), Marco Castori(Unknown), Hanadi Kazkaz(Creighton University), Helen Cohen(Uppsala University), Britta Berglund(Karolinska Institutet), Rodney Grahame(University College London Hospitals NHS Foundation Trust)
American Journal of Medical Genetics Part C Seminars in Medical Genetics
February 1, 2017
Cited by 482
Related Papers
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
A framework for the classification of joint hypermobility and related conditions
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|597
The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
|Nature Genetics|1995|512